Detection of Interferon Alpha Receptor 2 in Interferon Resistant HCV Patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Hepato-Gastroenterology

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 26176069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)

  2012cited by this paper
• Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1

  2011cited by this paper
• An overview of HCV molecular biology, replication and immune responses

  2011cited by this paper
• Interferon in the treatment of chronic hepatitis C: a drug caught between past and future

  2011cited by this paper
• Treatment of Hepatitis C Infections with Interferon: A Historical Perspective

  2010cited by this paper
• Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

  2010cited by this paper
• Epidemiology of hepatitis C virus infection in Pakistan.

  2008cited by this paper
• Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists.

  2008cited by this paper
• Genetic History of Hepatitis C Virus in East Asia

  2008cited by this paper
• A Conserved IFN-α Receptor Tyrosine Motif Directs the Biological Response to Type I IFNs1

  2008cited by this paper
• Investigating the endemic transmission of the hepatitis C virus.

  2007cited by this paper
• Type I Interferon Receptors: Biochemistry and Biological Functions*

  2007cited by this paper
• IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.

  2005cited by this paper
• Quantification of Different Human Alpha Interferon Subtypes and Pegylated Interferon Activities by Measuring MxA Promoter Activation

  2005cited by this paper
• Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study

  2004cited by this paper
• Interaction between hepatitis C virus proteins and host cell factors.

  2002cited by this paper
• The Domains Required to Direct Core Proteins of Hepatitis C Virus and GB Virus-B to Lipid Droplets Share Common Features with Plant Oleosin Proteins*

  2002cited by this paper
• Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

  2002cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• Hepatitis C virus and interferon resistance.

  2000cited by this paper
• New Structural and Functional Aspects of the Type I Interferon-Receptor Interaction Revealed by Comprehensive Mutational Analysis of the Binding Interface*

  2000cited by this paper
• Role of the Intracellular Domain of the Human Type I Interferon Receptor 2 Chain (IFNAR2c) in Interferon Signaling

  2000cited by this paper
• Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group.

  1995cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• Cytokines and STATs: how can signals achieve specificity?

  1995cited by this paper
• Signal transduction and activation of gene transcription by interferons.

  1995cited by this paper
• Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).

  1994cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

  1991cited by this paper

• No citing papers are available for this paper.